Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Ammonium Hydroxide | HCID 14923 | — |
| Reactant | 4-Nitrophenyl chloroformate | HCID 82129 | — |
| Reactant | 1-{1-[(R)-2-amino-3-(4-methoxyphenyl)propionyl]-4-cyclohexylpiperidin-4-yl}butan-1-one | HCID 66987681 | — |
| Reactant | HCID 178478693 | HCID 178478693 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 178450013 | HCID 178450013 | 32.3% |
Reaction Steps
30 mg (0.15 mmol) of 4-nitrophenyl chloroformate are added, at 0° C., to 57 mg (0.14 mmol) of 1-{1-[(R)-2-amino-3-(4-methoxyphenyl)propionyl]-4-cyclohexylpiperidin-4-yl}butan-1-one (cf. preparation 2-3) dissolved in 2 ml of DCM. The reaction mixture is stirred for 4 hours at room temperature. The reaction is stopped by adding aqueous NH4OH solution and the organic compounds are extracted with DCM. The organic phase is then washed with water and dried over MgSO4, filtered and concentrated. The oil obtained is dissolved in DMF at 80° C., and 52 mg (0.28 mmol) of 2-(1H-[1,2,3]triazol-4-yl)ethylamine dihydrochloride and 0.1 ml (0.72 mmol) of triethylamine are then added. The reaction mixture is stirred at 80° C. for 10 minutes. After cooling to room temperature, dichloromethane is added and the organic phase is washed with 1N sodium hydroxide. The organic phase is dried over MgSO4, filtered and concentrated. The crude product obtained is chromatographed on silica gel (eluent: 93/7 DCM/MeOH). 25 mg of 1-[(R)-2-(4-butyryl-4-cyclohexylpiperidin-1-yl)-1-(4-methoxybenzyl)-2-oxoethyl]-3-[2-(1H-[1,2,3]triazol-4-yl)ethyl]urea are obtained in the form of a white solid in a yield of 32%.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08962846B2 |
|---|
| Source dataset | uspto-grants-2015_02 |
|---|
| ORD ID | ord-05203183a6e44d29a84b7a19b795d2fb |
|---|
| Source note | uspto-grants-2015_02 |
|---|